5 completed, 3 unknown, 1 withdrawn. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Unknown 3, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Altitude Sickness: new trials by email Literature Review of Altitude Sickness trials Research Report on Altitude Sickness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill Suxiao Jiuxin Pill, Placebo - Acute Mountain Sickness | Phase 2 / Phase 3 | Unknown | Peking University First Hospital | 168 | 2024-08-01 | 2024-08-12 |
| Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) T89 capsule, Placebo capsule - Acute Mountain Sickness (AMS) | Phase 3 | Completed | Tasly Pharmaceuticals, Inc. | 853 | 2021-07-21 | 2024-08-13 |
| Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD Acetazolamide, Placebo - Chronic Obstructive Pulmonary Disease, Altitude Sickness | Phase 3 | Unknown | University of Zurich | 100 | 2021-06-01 | 2023-03-03 |
| Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide, Placebo - Right Heart Function, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | University of Zurich | 100 | 2021-05-01 | 2022-11-02 |
| Inhaled Budesonide for Altitude Illness Prevention Budesonide, Placebo - Altitude Sickness | Phase 3 | Withdrawn | University of Colorado, Denver | 2017-03-06 | 2017-03-13 | |
| Altitude Sickness Prevention and Efficacy of Comparative Treatments Budesonide, Acetazolamide, Placebo - Acute Mountain Sickness | Phase 3 | Completed | Stanford University | 103 | 2016-08-01 | 2018-12-12 |
| Drug Combination on Exercise Performance at High Altitude ambrisentan and theophylline, placebo - Acute Mountain Sickness | Phase 2 / Phase 3 | Completed | University of Montana | 28 | 2013-08-01 | 2016-02-26 |
| Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) Ibuprofen, Placebo - Altitude Sickness | Phase 3 | Completed | Stanford University | 89 | 2010-07-01 | 2018-12-13 |
| Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness Anti-oxidant supplementation, Matched placebo for anti-oxidant supplementation - Acute Mountain Sickness | Phase 3 | Completed | Altitude Physiology Expeditions | 83 | 2003-03-01 | 2008-04-22 |
Pulmonary Disease, Chronic Obstructive (2) · Hypertension, Pulmonary (1) · Hypoxia (1)
Respiration Disorders (9) · Respiratory Tract Diseases (9) · Chronic Disease (2) · Disease Attributes (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiovascular Diseases (1) · Hypertension (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1) · Vascular Diseases (1)
Acetazolamide (3) · Budesonide (2) · Ibuprofen (1) · Sugars (1) · Theophylline (1) · ambrisentan (1)
Stanford University (2) · University of Zurich (2) · Altitude Physiology Expeditions (1) · Peking University First Hospital (1) · Tasly Pharmaceuticals, Inc. (1) · University of Colorado, Denver (1) · University of Montana (1)
United States (4) · Kyrgyzstan (2) · China (1) · United Kingdom (1)
Grant S Lipman (1) · Grant S Lipman, MD (1) · Henry H Sun, PhD, MD (1) · Kenneth Baillie (1) · Konrad E Bloch (1) · Michael Furian (1) · Ryan Paterson, MD, DiMM (1) · Silvia Ulrich, Prof (1) · Talant M Sooronbaev (1) · Talant M Sooronbaev, MD (1) · Yan Zhang, M.D. (1) · Yong Huo, M.D. (1)
PMID 19273551, PMID 22440488, PMID 23270443, PMID 24465370, PMID 28668540